126 related articles for article (PubMed ID: 2953558)
1. Experimental thymidine kinase-deficient HSV-1 keratitis: therapeutic attempts.
Maudgal PC; De Clercq E; Huyghe P
Curr Eye Res; 1987 Apr; 6(4):579-84. PubMed ID: 2953558
[TBL] [Abstract][Full Text] [Related]
2. Experimental stroma herpes simplex keratitis. Influence of treatment with topical bromovinyldeoxyuridine and trifluridine.
Maudgal PC; De Clercq E; Descamps J; Missotten L; Wijnhoven J
Arch Ophthalmol; 1982 Apr; 100(4):653-6. PubMed ID: 6803747
[TBL] [Abstract][Full Text] [Related]
3. (S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine in the therapy of thymidine kinase-positive and -deficient herpes simplex virus experimental keratitis.
Maudgal PC; De Clercq E
Invest Ophthalmol Vis Sci; 1991 May; 32(6):1816-20. PubMed ID: 1851733
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of 9-(2-phosphonylmethoxyethyl)adenine in the therapy of TK+ and TK- herpes simplex virus experimental keratitis.
Maudgal PC; De Clercq E
Curr Eye Res; 1991; 10 Suppl():139-42. PubMed ID: 1650660
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of (S)-HPMPA against thymidine kinase-deficient herpes simplex virus-keratitis.
Maudgal PC; De Clercq E; Huyghe P
Invest Ophthalmol Vis Sci; 1987 Feb; 28(2):243-8. PubMed ID: 8591903
[TBL] [Abstract][Full Text] [Related]
6. Ac2IDU, BVDU, and thymine arabinoside therapy in experimental herpes keratitis.
Hettinger ME; Pavan-Langston D; Park NH; Albert DM; De Clercq E; Lin TS
Arch Ophthalmol; 1981 Sep; 99(9):1618-21. PubMed ID: 7283815
[TBL] [Abstract][Full Text] [Related]
7. Effects of phosphonylmethoxyalkyl-purine and -pyrimidine derivatives on TK+ and TK- HSV-1 keratitis in rabbits.
Maudgal PC; De Clercq E
Antiviral Res; 1991 Jul; 16(1):93-100. PubMed ID: 1663731
[TBL] [Abstract][Full Text] [Related]
8. Bromovinyldeoxyuridine (BVDU) and trifluorothymidine (TFT) in dendritic corneal ulceration: a double blind controlled study.
Power WJ; Benedict-Smith A; Hillery M; Brady K; Collum LM
Curr Eye Res; 1991; 10 Suppl():183-7. PubMed ID: 1907535
[TBL] [Abstract][Full Text] [Related]
9. Randomised double-blind trial of bromovinyldeoxyuridine (BVDU) and trifluorothymidine (TFT) in dendritic corneal ulceration.
Power WJ; Benedict-Smith A; Hillery M; Brady K; Collum LM
Br J Ophthalmol; 1991 Nov; 75(11):649-51. PubMed ID: 1751456
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of bromovinyldeoxyuridine in the treatment of herpes simplex virus and varicella-zoster virus eye infections.
Maudgal PC; De Clercq E; Missotten L
Antiviral Res; 1984 Oct; 4(5):281-91. PubMed ID: 6335020
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of bromovinyldeoxyuridine-related compounds in the treatment of experimental herpes simplex keratitis.
Maudgal PC; De Clercq E
Arch Ophthalmol; 1985 Sep; 103(9):1393-7. PubMed ID: 4038133
[TBL] [Abstract][Full Text] [Related]
12. (E)-5-(2-bromovinyl)-2'-Deoxyuridine in the treatment of experimental herpes simplex keratitis.
Maudgal PC; De Clercq E; Descamps J; Missotten L; De Somer P; Busson R; Vanderhaeghe H; Verhelst G; Walker RT; Jones AS
Antimicrob Agents Chemother; 1980 Jan; 17(1):8-12. PubMed ID: 7352751
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil (BrVaraU, VaraU) in the treatment of experimental herpes simplex virus type 1 keratitis in rabbits: comparison with (E)-5-(2-bromovinyl)-2'-deoxyuridine (BrVUdR).
Töpke H; Gräf M; Wutzler P; Herrmann G; Reefschläger J
Antiviral Res; 1988 Jul; 9(4):273-80. PubMed ID: 3202622
[TBL] [Abstract][Full Text] [Related]
14. Highly selective cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine derivatives for murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 thymidine kinase gene.
Balzarini J; De Clercq E; Verbruggen A; Ayusawa D; Seno T
Mol Pharmacol; 1985 Dec; 28(6):581-7. PubMed ID: 3001499
[TBL] [Abstract][Full Text] [Related]
15. Ocular penetration and efficacy of chloroethyldeoxyuridine against herpetic keratouveitis.
Maudgal PC; De Clercq E; Bernaerts R; Dieltiens M; Breemersch M; Van Eeckhoutte L
Invest Ophthalmol Vis Sci; 1986 Oct; 27(10):1453-8. PubMed ID: 3759363
[TBL] [Abstract][Full Text] [Related]
16. Comparative antiviral efficacies of cidofovir, trifluridine, and acyclovir in the HSV-1 rabbit keratitis model.
Romanowski EG; Bartels SP; Gordon YJ
Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):378-84. PubMed ID: 9950596
[TBL] [Abstract][Full Text] [Related]
17. Human interferon alpha A or alpha D and trifluridine treatment for herpetic keratitis in rabbits.
Trousdale MD; Nesburn AB
Invest Ophthalmol Vis Sci; 1984 Apr; 25(4):480-3. PubMed ID: 6423563
[TBL] [Abstract][Full Text] [Related]
18. Thymidylate synthase is the principal target enzyme for the cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine against murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 or type 2 thymidine kinase gene.
Balzarini J; De Clercq E; Verbruggen A; Ayusawa D; Shimizu K; Seno T
Mol Pharmacol; 1987 Sep; 32(3):410-6. PubMed ID: 2823092
[TBL] [Abstract][Full Text] [Related]
19. Carbocyclic 5-iodo-2'-deoxyuridine (C-IDU) and carbocyclic (E)-5-(2-bromovinyl)-2'-deoxyuridine (C-BVDU) as unique examples of chiral molecules where the two enantiomeric forms are biologically active: interaction of the (+)- and (-)-enantiomers of C-IDU and C-BVDU with the thymidine kinase of herpes simplex virus type 1.
Balzarini J; De Clercq E; Baumgartner H; Bodenteich M; Griengl H
Mol Pharmacol; 1990 Mar; 37(3):395-401. PubMed ID: 2156153
[TBL] [Abstract][Full Text] [Related]
20. Corneal epithelial dysplasia after trifluridine use.
Maudgal PC; Van Damme B; Missotten L
Graefes Arch Clin Exp Ophthalmol; 1983; 220(1):6-12. PubMed ID: 6403411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
